Pharma & Biotech

BioNTech is charting a bold new course beyond its pandemic-era success, positioning artificial intelligence as the cornerstone of its next...

Baidu is making strategic moves on multiple fronts that could significantly enhance its standing in the global artificial intelligence competition....

Bristol-Myers Squibb has secured a significant regulatory achievement with the FDA granting Fast-Track status to its Alzheimer's disease candidate, BMS-986446....

The pharmaceutical industry is experiencing a significant breakthrough, with Eli Lilly emerging as a frontrunner in the current market upswing....

Biotechnology leader Regeneron demonstrated the powerful impact of regulatory progress on investor sentiment yesterday. A pair of significant developments from...

The biotechnology sector has a new standout performer as Intellia Therapeutics demonstrates significant momentum across multiple fronts. Clinical trial progress,...

Medical technology giant Becton Dickinson enters October with notable momentum, propelled by multiple strategic developments that could signal a potential...

aTyr Pharma's stock continues its downward spiral as disappointing clinical trial results trigger a massive selloff. The biotechnology firm's shares...

Biogen has achieved significant regulatory and clinical milestones for its Alzheimer's treatment Leqembi, positioning the biotechnology firm for potential growth...

The neuroscience sector appears poised for significant transformation, and Axsome Therapeutics is emerging as a potential standout performer. With its...